SuspendedNCT04245917
Natural History Study of MNGIE
Studying Mitochondrial neurogastrointestinal encephalomyopathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Entrada Therapeutics, Inc.
- Principal Investigator
- Michio Hirano, MDColumbia University
- Intervention
- Non-interventional(other)
- Enrollment
- 60 target
- Eligibility
- 5 years · All sexes
- Timeline
- 2020 – 2026
Study locations (5)
- Children's Hospital Colorado, Aurora, Colorado, United States
- Columbia University, New York, New York, United States
- Baylor St Luke's Medical Center and Texas Children's Hospital at Baylor College of Medicine, Houston, Texas, United States
- Ege University Medical Faculty; Department of Pediatrics, Bornova, İzmir, Turkey (Türkiye)
- Gazi Üniversitesi Tıp Fakültesi, Ankara, Turkey (Türkiye)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04245917 on ClinicalTrials.gov